Orion Biotech Opportunities Corp.
ORIANASDAQFinancial Services
$10.23
+$0.00(+0.00%)
Market Cap$0
P/E Ratio—
52W High$12.0
52W Low$9.71
Orion Biotech Opportunities Corp. (ORIA) · Income Statement
Annual, quarterly, or TTM views · SEC 10-K & 10-Q via FMP · adjust period and M/B/T below.
FMP · ORIA · as of 2026-06-09
Financial statements
Revenue · Gross Profit · Net Income
| Breakdown | 2022-12 | 2021-12 |
|---|---|---|
| Revenue | ||
| Revenue | $0.00B | $0.00B |
| Cost of Revenue | $0.00B | $0.00B |
| Gross Profit | $0.00B | $0.00B |
| Gross Margin %(computed) | — | — |
| Operating Expenses | ||
| R&D Expenses | $0.00B | $0.00B |
| G&A Expenses | $0.00B | $0.00B |
| Total Operating Expenses | $0.00B | $0.00B |
| Operating Income | ($0.00B) | ($0.00B) |
| Operating Margin %(computed) | — | — |
| Interest Income | $0.00B | $0.00B |
| Interest Expense | $0.00B | $0.00B |
| Income Before Tax | $0.01B | ($0.00B) |
| Income Tax Expense | ($0.01B) | $0.00B |
| Net Income | $0.02B | ($0.00B) |
| Net Margin %(computed) | — | — |
| Per Share & EBITDA | ||
| EPS (Basic) | $0.92 | $-0.03 |
| Wtd Avg Shares | 0.02B | 0.02B |
| EBITDA | ($0.01B) | ($0.00B) |
| EBITDA Margin %(computed) | — | — |
Data source: Financial Modeling Prep · Last updated: 2026-06-09 · USD · B
Explore more Orion Biotech Opportunities Corp. data
About Orion Biotech Opportunities Corp. (ORIA) Income Statement
Orion Biotech Opportunities Corp. (ORIA) income statement data is sourced from SEC Form 10-K and 10-Q filings. For fiscal year 2022, ORIA reported revenue of $0.00B, gross profit of $0.00B (gross margin —), and net income of $0.02B — a net profit margin of —.
Frequently asked questions
ORIA · 4 questionsOrion Biotech Opportunities Corp. (ORIA) reported revenue of $0.00B for 2022, down —% year-over-year.
ORIA revenueORIA salesannual revenue YoYincome statement
· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-09